<!DOCTYPE html>
<!--[if lt IE 7]><html class="no-js ie6 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 7]><html class="no-js ie7 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 8]><html class="no-js ie8 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 9]><html class="no-js ie9 ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><!<![endif]-->
<!--[if (gt IE 9)|(gt IEMobile 7)|!(IEMobile)|!(IE)]><!--><html class="no-js" lang="en" xmlns="http://www.w3.org/1999/xhtml"><!--<![endif]-->
<head>
       
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"c2a5bf7b54","applicationID":"2502042","transactionName":"IlheTBRdCQ8DQxxWWg9DVVYSHRUWBF1aVmoSX19P","queueTime":0,"applicationTime":233,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta name="keywords" content="pharma, biotech, clinical trial costs, research, DVC, dynport, biodefense, infectious, emerging diseases" />
  <meta name="description" content="Tufts University: Pharma spends $4 to $6 billion each year on “procedures that generate extraneous clinical trial data.”" />
  <meta name="geo.region" content="US" />
  <meta content="article" property="og:type" />
  <meta content="Curiosity and the bottom line, plus grumpy cats and megabats" property="og:title" />
  <meta content="Tufts University: Pharma spends $4 to $6 billion each year on “procedures that generate extraneous clinical trial data.”" property="og:description" />
  <meta content="http://www.csc.com/dvc/blog/41185/92214-curiosity_and_the_bottom_line_plus_grumpy_cats_and_megabats" property="og:url" />
  <meta content="en-US" property="og:locale" />
  <meta content="Computer Sciences Corporation" property="og:site_name" />
  <link rel="canonical" href="92214-curiosity_and_the_bottom_line_plus_grumpy_cats_and_megabats.html" />
  <title>Curiosity and the bottom line, plus grumpy cats and megabats | CSC</title>

  <script type="text/javascript">
    var responsive=true ;
  </script>


    <script type="text/javascript">
      var responsive = true;
    </script>
    <!--[if lte IE 8]>
      <script type="text/javascript">responsive = false;</script>
    <![endif]-->
    <![if gt IE 8]>
    <meta name="viewport" content="initial-scale=1,maximum-scale=1,width=device-width" />
     <link href="../../../stylesheets/user/global-bundle-78733079cb421825fca5a903046c770c.css" media="all" rel="stylesheet" type="text/css" />
    <![endif]>
    <!--[if lte IE 8]>
       <link href="../../../stylesheets/user/global_non_responsive-bundle-9ef563e134b588f9a45b5060ad4b78aa.css" media="all" rel="stylesheet" type="text/css" />
    <![endif]-->
    

       <link href="../../../assets/public/comments-7c37505c1a6e388ce4e34a78fbb12494.css" media="screen" rel="stylesheet" type="text/css" />
    <link href="../../../stylesheets/user/blogdetail-492cb34d506631f042187b0a924bc649.css" media="all" rel="stylesheet" type="text/css" />

    <![if gt IE 8]>
    <script src="../../../javascripts/user/global-bundle-8889b0584423b7383dba5816ff101fd5.js" type="text/javascript"></script>
    <![endif]>
    <!--[if lte IE 8]>
      <script src="../../../javascripts/user/global_non_responsive-bundle-8385e9848036be955101f89324885409.js" type="text/javascript"></script>
    <![endif]-->
    


  <!--[if lt IE 9]>
  <script src="../../../javascripts/user/printshiv-min-68e071550e9b2f652850bf54693181a1.js" type="text/javascript"></script>
  <!<![endif]-->

<script>
$csc().gigya.init("2_znZ6oKy7notCLVoNArGFVv8LPRNmj8f3YN1TN-Hxt0Q1xFL2-tD8kc84bP_jARhA");
</script>


  <script type="text/javascript">
    include_default_css = true;
    //translations
    ls_header = "CSC Live Search: Quick Results";
    ls_see = "Don't see what you're looking for?";
          ls_search = "Search all over";
    ls_results = "for more results";
    mn_navigation = "Navigation";
    mn_countrySelect = "Worldwide";
    mn_search = "Search";
  </script>

  
</head>
<body itemscope itemtype="http://schema.org/WebPage">
    <script src="../../../javascripts/user/mbox_js-min-c4e062b0e669784dee7d810bbaa1f418.js" type="text/javascript"></script>
  <script type="text/javascript">
          setupCampaignTracking();
          var s_code = null;
          var _gaq = null;
          visitorOrg = null;
          var db_err = null;
        </script>
    <script src="../../../javascripts/user/s_code-min-38fd02ddea4b57c76bed86493f62daa0.js" type="text/javascript"></script>
  
  <script type="text/javascript">
    var contentID = '';
    var zoneID = '';
    var contentTypeID = '';
    s.charSet="UTF-8";
    s.pageName="DVC LLC:Blogs:DVC News for Partners:92214-Curiosity and the bottom line, plus grumpy cats and megabats";
    s.channel=window.location.hostname;
    s.products="92214";
    s.prop1="DVC LLC";
    s.prop2="DVC LLC:Blogs";
    s.prop3="DVC LLC:Blogs:DVC News for Partners";
    s.prop8="Blogs";
    s.prop9="92214";
    s.prop10="1819";
    s.prop16="Managed Multipurpose Sites";
    s.prop19="";
    s.prop37="Zack Cannon";
    s.prop38="Awareness";
    s.eVar44 = "D=c38";
    contentID="92214";
    zoneID = "265";
    contentTypeID = "17";
    s.eVar9="D=c1";
    s.eVar10="D=c16";
    s.eVar11="Blogs";
    s.eVar12="D=pageName";
    s.eVar13="D=c19";
    s.eVar45="D=c37";
    s.eVar8="D=c9";
    
    s.prop12 = document.location.pathname + document.location.search;
    s.prop13="en-US";
    s.hier1 = document.location.hostname + ':' + s.pageName;
    createPublicPage(contentID,contentTypeID,s.prop8,zoneID,s.prop1,s.prop19);


    $csc().analytics.visitorOrg.buildPublic();
    _gaq = _gaq || [];
   setupGA(_gaq);

  </script>

  <script type="text/javascript">
  <!-- if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-') //-->
  </script>
  <noscript>
  <a href="http://www.omniture.com">
    <img src="http://computersciences.112.2o7.net/b/ss/csccom/1/H.15.1--NS/0" height="1" width="1" style="border: 0;" alt="" />
  </a>
  </noscript>

  <div class='mboxDefault'></div>
  <script type='text/javascript'>
  mboxCreate('page',
'entity.id=92214',
'entity.name=Curiosity and the bottom line, plus grumpy cats and megabats',
'entity.pageURL=/dvc/blog/41185/92214-curiosity_and_the_bottom_line_plus_grumpy_cats_and_megabats',
'entity.message=Tufts University: Pharma spends $4 to $6 billion each year on “procedures that generate...',
'entity.categoryId=265',
'entity.content_type_id=17',
'entity.thumbnailURL=',
'entity.key_content_type=0',
'entity.locale=en-US',
'entity.listing=0',
'user.categoryId=265');
  </script>

<div id="viewporter">
  <header>
    <div id="mobiTagLine">
      <p>
        A global leader in providing technology enabled business solutions and services
      </p>
    </div>
    <div class="mainLogo">
      <a href="../../../index.html">
        <img src="../../../assets/new/logo.png" alt="CSC Logo - A global leader in providing technology enabled business solutions and services." /></a>
      <span class="globalHeadline">A global leader in providing technology enabled business solutions and services.</span>
    </div>
    <div id="country">
      <div><a href="javascript:void(0);" class="countryHide countrySelector">Worldwide</a><a id="countrySelector" class="countryHide countrySelector"></a></div>
      <div id="country-select" style="display:none;">
        <!--link href="/stylesheets/user/country_select_styles-min.css" rel="stylesheet" type="text/css" /-->
<div class="unitedstates">
	<a href="../../../index.html">United States</a>
</div>
<div class="australia">
	<a href="../../../au.html">Australia</a>
</div>
<div class="austria">
	<a href="../../../de.html">Austria</a>
</div>
<div class="belgium">
	<a href="../../../be.html">Belgium</a>
</div>
<div class="brazil">
	<a href="../../../br_pt.html">Brazil</a>
</div>
<div class="bulgaria">
	<a href="../../../eastern_europe.html">Bulgaria</a>
</div>
<div class="canada">
	<a href="../../../ca_en.html">Canada</a>
</div>
<div class="canada">
	<a href="../../../ca_fr.html">Canada [fr]</a>
</div>
<div class="chile">
	<a href="../../../cl.html">Chile</a>
</div>
<div class="china">
	<a href="../../../cn_cn.html">China</a>
</div>
<div class="czech">
	<a href="../../../eastern_europe.html">Czech Republic</a>
</div>
<div class="denmark">
	<a href="../../../dk.html">Denmark</a>
</div>
<div class="france">
	<a href="../../../fr.html">France</a>
</div>
<div class="germany">
	<a href="../../../de.html">Germany</a>
</div>
<div class="hongkong">
	<a href="../../../hk_en.html">Hong Kong</a>
</div>
<div class="india">
	<a href="../../../in.html">India</a>
</div>
<div class="italy">
	<a href="../../../it.html">Italy</a>
</div>
<div class="japan">
	<a href="../../../jp_jp.html">Japan</a>
</div>
<div class="korea">
	<a href="../../../kr.html">Korea</a>
</div>
<div class="lithuania">
	<a href="../../../lt.html">Lithuania</a>
</div>
<div class="luxembourg">
	<a href="../../../lu.html">Luxembourg</a>
</div>
<div class="malaysia">
	<a href="../../../my.html">Malaysia</a>
</div>
<div class="netherlands">
	<a href="../../../nl.html">Netherlands</a>
</div>
<div class="norway">
	<a href="../../../no.html">Norway</a>
</div>
<div class="poland">
	<a href="../../../eastern_europe.html">Poland</a>
</div>
<div class="portugal">
	<a href="../../../pt.html">Portugal</a>
</div>
<div class="romania">
	<a href="../../../eastern_europe.html">Romania</a>
</div>
<div class="singapore">
	<a href="../../../sg.html">Singapore</a>
</div>
<div class="slovakia">
	<a href="../../../eastern_europe.html">Slovakia</a>
</div>
<div class="southafrica">
	<a href="../../../za.html">South Africa</a>
</div>
<div class="spain">
	<a href="../../../es.html">Spain</a>
</div>
<div class="sweden">
	<a href="../../../se.html">Sweden</a>
</div>
<div class="switzerland">
	<a href="../../../de.html">Switzerland</a>
</div>
<div class="thailand">
	<a href="../../../th_en.html">Thailand</a>
</div>
<div class="unitedkingdom">
	<a href="../../../uk.html">United Kingdom</a>
</div>
<div class="vietnam">
	<a href="../../../vn_en.html">Vietnam</a>
</div>
<div class="vietnam">
	<a href="../../../vn_vn/index.html">Vietnam [vn]</a>
</div>

      </div>
      <div id="search">
        <form action="/search" method="get" name="searchForm" id="searchForm">
          <ul>
            <li>
              <input id="searchField" type="text" name="q"  />
              <input type="hidden" value="265" name="zone_id" id="gsa_zone_id" /><input type="hidden" value="en-US" name="locale" id="gsa_locale"/>
            </li>
            <li><input id="searchSubmit" class="hidden searchBtn" type="submit" /></li>
          </ul>
        </form>
      </div>
    </div>
    <nav id="mobiMainNav">
      <ul>
        <li id="mobiCountry"><a href="javascript:void(0);">&nbsp;</a> </li>
        <li id="mobiNav"><a href="javascript:void(0);">&nbsp;</a> </li>
        <li id="mobiSearchBtn"><a href="javascript:void(0);">&nbsp;</a> </li>
      </ul>
      <div id="mobileSearch" style="display:none">
        <div class="mobileSearchWrap">
          <input type="text" name="searchText" id="mobileSearchInput" /><a id="mobiSearchImage" href="javascript:void(0);"></a>
        </div>
      </div>
      <div id="mobileNav" style="display:none">
        <ul class="mobinav" style="">
	<li class="solutionsLink">
		<a href="../../offerings/44393.html">Services</a></li> 
	</li>
	<li class="successLink">
		<a href="../../ds/16190/16326-team_with_dvc.html">Partners</a></li>
	</li>
	<li class="insightsLink">
		<a href="../../ds/11646/15182-dvc_company_information.html">About Us</a></li>
	</li>
	<li class="contactLink">
		<a href="../../ds/16321/16362-job_openings.html">Careers</a></li>
	</li>
	<li class="aboutLink">
		<a href="../../contact_us.html">Contact Us</a>
	</li>
</ul>
      </div>
    </nav>
    <div id="loginSection">
      <div id="visitor_login_section" class="loginSection unhidden"><a href="javascript:void(0);" id="nav_account_create" onclick="accountPopupWindow('account_create');">Register</a><span class="nav_account_spacer">&nbsp;|&nbsp;</span><a href="javascript:void(0);" id="nav_account_login" onclick="accountPopupWindow('account_login');"><span class="nav_account_spacer">Login</span></a></div>
<div id="visitor_welcome_section" class="loginSection hidden"><span class="nav_account_spacer">Welcome,&nbsp;</span><label id="nav_edit_profile" style="cursor:pointer;" onclick="accountPopupWindow('editprofile');"><span id="visitor_name"></span></label><span class="nav_account_spacer">&nbsp;|&nbsp;</span><a href="../../../utils/logout_visitor.html" id="nav_logout_visitor">Log&nbsp;Out</a></div>
    </div>
    <div class="wrapper">
  <nav id="globalNav">
    <ul id="nav">
      <li id="solutionsLink">
	<a href="../../offerings/44393.html">Services</a></li>
      <li id="successLink">
        <a href="../../ds/16190/16326-team_with_dvc.html">Partners</a></li>
      <li id="insightsLink">
        <a href="../../ds/11646/15182-dvc_company_information.html">About Us</a></li>
      <li id="contactLink">
        <a href="../../ds/16321/16362-job_openings.html">Careers</a></li>
      <li id="aboutLink">
        <a href="../../contact_us.html">Contact Us</a>
      </li>
    </ul>
  </nav>
</div>
  </header>
  <div class="breadcrumbs wrapper" itemprop="breadcrumb">
    <ul class='breadCrumbs'> <li><a href='../../../index.html'>Home</a> / </li> <li><a href='../../../dvc.html'>DVC LLC</a> / </li> <li><a href='../41185.html'>DVC News Updates for Partners</a> / </li> <li>Curiosity and the bottom line, plus grumpy cats and megabats</li> </ul>
  </div>
  <nav class="mobiSecondaryNav">
    <ul>
      <li id="mobiBack"><a href="../41185.html">Back</a> </li>
      <li id="mobiBackLabel">&nbsp;</li>
      <li id="mobiMoreLinks"><a href="javascript:void(0);">More Links</a> </li>
    </ul>
  </nav>
  <div id="iscrollWrapper">
    <div class="scrollwrap">
      <!-- Content Start -->

      
<section id="mainContent" class="rightSideBar">
  <div class="wrapper">
    
    <!-- Share Bar Plugin DIV Container -->
<div id="gigyaButtons"></div>
<script type="text/javascript">
  $csc().gigya.showShareBar();
</script>
<!-- End Share Bar Code -->
    <article class="pageContent" itemprop="mainContentOfPage">
    <!-- Gigya Bar -->
    <article class="blogPost">
    <section>
      <h1>Curiosity and the bottom line, plus grumpy cats and megabats</h1>
      <time>2012-12-03</time>
      <p><h2><img alt="&quot;We wish you a peaceful holiday season, and a joyous new year.&quot; on blue background with snowflakes" src="http://assets1.csc.com/dvc/images/holidaybanner2012.gif" height="234" width="591" /></h2>
<h2></h2>
<h2><strong>Feature: Constricting the Cat: Curiosity Kills the Bottom Line</strong></h2>
<p><a target="_blank" href="http://csdd.tufts.edu/news/complete_story/pr_ir_nov-dec_2012"><img style="float: right; margin: 10px;" alt="Curious cat in a wrapped holiday gift box with red bow" src="http://assets1.csc.com/dvc/images/holiday_catinbox.gif" height="232" width="350" /></a>The pharmaceutical industry spends between $4 and $6 billion each year on “procedures that generate extraneous clinical trial data,” according to a Tufts University Center for the Study of Drug Development <a target="_blank" href="http://csdd.tufts.edu/news/complete_story/pr_ir_nov-dec_2012">report</a>.  One in every five procedures performed in late-stage trials—at a cost averaging $1 million per trial—were found to be unnecessary.</p>
<p>Scientists are famously and insatiably curious. We question everything, and tinker endlessly in search of the elusive, “Why?” Yet business and science are antithetical. Businesses have trodden “doing more with less” from a management cliché to standard practice—if it doesn’t increase efficiency, decrease costs or boost the bottom line, it’s history.</p>
<p>But there’s always government, right? Not quite. While the government is indeed funding medical countermeasures with no viable commercial market (including DynPort’s own plague and botulinum neurotoxin vaccines), there’s not an unlimited pot of money. In fact, amid widespread federal belt-tightening, these funds too are shrinking.</p>
<p>We’ve said for years that government contractors must distinguish “need-to-know” from “nice-to-know.” If that follow-on study would produce interesting nonclinical data but isn’t required by the FDA, it won’t make the cut. You won’t get to scrutinize every remarkable result; research must directly contribute to achieving your client’s goals. But by exercising curiosity’s cousin, creativity, you can streamline your studies to deliver within budget and on schedule.</p>
<p><strong>More on the Tufts study:</strong></p>
<p>Are clinical trial investigators <a target="_blank" href="http://www.fiercebiotech.com/story/are-clinical-trial-investigators-guilty-mission-creep/2012-11-07#ixzz2BktyeS22">wasting billions</a> of bucks on mission creep? (FierceBiotech)</p>
<p><a target="_blank" href="http://csdd.tufts.edu/files/uploads/nov-dec_2012_ir_summary.pdf">Study summary</a> (PDF, 43K)</p>
<p><a target="_blank" href="http://csdd.tufts.edu/reports/purchase_single_impact_report?issue=Vol.%2014%20No.%206">Purchase a full study report</a> from Tufts ($125)</p>
<p style="font-size: medium; font-weight: bold;">More on government contracting, from our archives:</p>
<p><a target="_blank" href="http://assets1.csc.com/dvc/downloads/20100408_DVC_Lessons_Learned_Web_RT.pdf">Lessons Learned and Best Practices in Medical Countermeasure Development</a> (PDF, 307K)</p>
<hr />
<h2></h2>
<h2><strong>TechWatch: Science News Tidbits</strong></h2>
<p><a target="_blank" href="http://www.fiercevaccines.com/story/hiv-antibody-development-discovery-advances-vaccine-search/2012-10-23#ixzz2AQ29A84M">HIV antibody development discovery advances vaccine search</a><br /><a target="_blank" href="http://www.fiercevaccines.com/story/hiv-antibody-development-discovery-advances-vaccine-search/2012-10-23#ixzz2AQ29A84M"><img style="float: right; margin: 10px;" alt=" Scanning electron micrograph of HIV-1 virions budding from a cultured lymphocyte. Multiple=" /></a>“Over the past few years, scientists have identified two potent antibodies (and dozens more 'broadly neutralizing antibodies') that could target most of the thousands of strains of HIV. Still, a key piece of knowledge in developing a vaccine--understanding how these antibodies develop--has remained elusive. But researchers are getting closer. In a study published in the journal <em>Nature Medicine</em>, researchers from the Centre for the AIDS Programme of Research in South Africa said they discovered a change in the outer coating of the virus that enabled two HIV-infected women to develop broadly neutralizing antibodies, <em>The Wall Street Journal</em> reports. One of the women had neutralized 88% of 225 HIV subtypes after three years with the virus, and the other woman neutralized 46% of 41 subtypes of the virus after two years of infection." <em>(Source: Alison Bryant, FierceVaccines)</em><br /> <strong>Journal article</strong>, from <em>Nature Medicine</em> (subscription required for full text): <a target="_blank" href="http://www.nature.com/nm/journal/v18/n11/full/nm.2985.html">Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape</a></p>
<p><em>Image: Scanning electron micrograph of HIV-1 virions budding from a cultured lymphocyte. Multiple round bumps on cell surface represent sites of assembly and budding of virions.  Photo credit: CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManus</em></p>
<p><a target="_blank" href="http://www.medicalnewstoday.com/releases/251876.php?utm_source=BNT+October+25,+2012&utm_campaign=BNT102512&utm_medium=email">Antibiotic effectiveness against MRSA restored by additive</a><br /> "Researchers from North Carolina State University have increased the potency of a compound that reactivates antibiotics against methicillin-resistant <em>Staphylococcus aureus</em> (MRSA), an antibiotic-resistant form of <em>Staphylococcus</em> that is notoriously difficult to treat. Their improved compound removes the bacteria's antibiotic resistance and allows the antibiotic to once again become effective at normal dosage levels. NC State chemist Christian Melander had previously proven the effectiveness of a 2-aminoimidazole compound in reactivating antibiotics against resistant bacterial strains. However, the original compound was not potent enough. In his latest work, described in a paper appearing in <em>Angewandte Chemie</em>, Melander, research assistant professor Roberta Worthington and graduate student Tyler Harris have solved the potency issue, bringing them one step closer to <em>in vivo</em> testing."  <em>(Source: Medical News Today)</em><br /> <strong>Journal article</strong>, from <em>Angewandte Chemie</em> (subscription required for full text): <a target="_blank" href="http://onlinelibrary.wiley.com/doi/10.1002/anie.201206911/abstract">Potent Small-Molecule Suppression of Oxacillin Resistance in Methicillin-Resistant <em>Staphylococcus aureus</em></a></p>
<p><a target="_blank" href="http://www.technologyreview.com/news/506511/breakthrough-offers-a-better-way-to-make-drugs/?utm_campaign=newsletters&utm_source=newsletter-daily-all&utm_medium=email&utm_content=20121106">Breakthrough offers a better way to make drugs: “continuous flow” manufacturing</a><br /> “Despite the huge amounts of money that the pharmaceutical industry spends on drug discovery, it is notoriously old-fashioned in how it actually makes its products. Most drugs are made in batch processes, in which the ingredients, often powders, are added in successive and often disconnected steps. The process resembles a bakery more than it does a modern chemistry lab. That could be about to change. This summer, a team of researchers from MIT and Swiss pharmaceutical company Novartis proved that a continuous production line that integrated several new chemical processes and equipment specially designed for the project could make a higher quality drug faster, and in a less wasteful manner.  This more nimble method may even create more opportunities in early drug discovery. In their continuous-manufacturing process, raw ingredients are fed into a parade of heaters, spinners, extractors, and sensors that relay the intermediates through chemical reactions. At the end, round, coated pills fall out. … The method could bring new types of molecules into drug discovery.” <em>(Source: Susan Young, MIT Technology Review)</em></p>
<hr />
<h2></h2>
<h2><strong>Industry and Government Contracting News</strong></h2>
<h3><strong>Biopharma and Biodefense</strong></h3>
<p><a target="_blank" href="http://www.azonano.com/news.aspx?newsID=25813"><img style="float: right; margin: 10px;" alt="3-D model of the outside surface of the enzyme that helps M. tuberculosis bacteria resist common antibiotics. Blue indicates positively charged atoms; red indicates negatively charged atoms. A peptidoglycan (green) is bound inside the enzyme’s active site. Credit: Mario A. Bianchet" src="http://assets1.csc.com/dvc/images/3Dtuberculosis_enzyme.png" height="222" width="200" /></a>Researchers at Johns Hopkins have figured out the <a target="_blank" href="http://biohealthinnovation.org/index.php/bhi-news-articles/702-researchers-employ-x-ray-crystallography-to-build-3-d-model-of-tb-protein?utm_source=biohealth-innovation-news&utm_medium=gazetty&utm_campaign=10-29-2012">three-dimensional shape</a> of the protein responsible for creating unique bonds within the cell wall of the bacteria that cause tuberculosis.</p>
<p><em>Image: 3-D model of the outside surface of the enzyme that helps M. tuberculosis bacteria resist common antibiotics. Blue indicates positively charged atoms; red indicates negatively charged atoms. A peptidoglycan (green) is bound inside the enzyme’s active site. Credit: Mario A. Bianchet</em></p>
<p>How does polio vaccine reach remote corners of the world? By <a target="_blank" href="http://www.npr.org/blogs/health/2012/10/23/163496511/how-does-the-polio-vaccine-reach-a-remote-corner-of-the-world">donkey</a>, of course.</p>
<p>Plants offer low-cost alternative for <a target="_blank" href="http://www.eurekalert.org/pub_releases/2012-10/asu-ppa102412.php?utm_source=BNT,+October+26,+2012&utm_campaign=BNT102612&utm_medium=email">diagnosis</a> of West Nile virus.</p>
<p>A methamphetamine vaccine protected against meth intoxication in <a target="_blank" href="http://www.fiercevaccines.com/story/scripps-researchers-develop-methamphetamine-vaccine/2012-11-07?utm_medium=nl&utm_source=internal">preclinical studies</a>.</p>
<p>Superbug MRSA <a target="_blank" href="http://www.eurekalert.org/pub_releases/2012-11/uom-smi110512.php?utm_source=BNT,+November+7,+2012&utm_campaign=BNT110712&utm_medium=email">identified</a> in U.S. wastewater treatment plants; elsewhere, team <a target="_blank" href="http://www.cidrap.umn.edu/cidrap/content/other/resistance/news/nov1412scan.html">tracks</a> hospital MRSA outbreak using whole-genome sequencing. <strong>Journal article</strong>, from <em>The Lancet Infectious Diseases</em> (subscription required for full text): <a target="_blank" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70268-2/abstract">Whole-genome sequencing for analysis of an outbreak of methicillin-resistant Staphylococcus aureus: a descriptive study</a></p>
<p>A <a target="_blank" href="http://www.bloomberg.com/news/2012-11-14/serum-of-india-s-meningitis-drug-cleared-for-warm-storage.html">meningitis vaccine</a> developed by the Serum Institute of India Ltd. remains effective at high temperatures, allowing it to be used in locations that lack refrigeration.</p>
<p>Ebola, Marburg and Lassa viruses are often referred to as emerging diseases, but scientists say these life-threatening viruses have <a target="_blank" href="http://www.homelandsecuritynewswire.com/dr20121114-scientists-some-diseases-designated-as-emerging-have-been-around-for-centuries?utm_source=BNT,+November+14,+2012&utm_campaign=BNT111412&utm_medium=email">been around</a> for centuries.</p>
<p><a target="_blank" href="http://www.nti.org/gsn/article/australian-scientists-develop-nepah-virus-vaccine/?utm_source=BNT,+November+2,+2012&utm_campaign=BNT110212&utm_medium=email"><img style="float: left; margin: 10px;" alt="Head of a “Gray-headed Flying Fox,” Pteropus poliocephalus.The gray-headed flying fox is a member of the order Chiroptera, and the subfamily Megachiroptera, or “megabats,&quot; which range from 2.4 to 16 inches in length." src="http://assets1.csc.com/dvc/images/gray_headed_flying_fox.gif" height="181" width="250" /></a>Scientists develop a <a target="_blank" href="http://www.nti.org/gsn/article/australian-scientists-develop-nepah-virus-vaccine/?utm_source=BNT,+November+2,+2012&utm_campaign=BNT110212&utm_medium=email">Hendra virus vaccine</a>. By vaccinating horses, humans will also be protected from this zoonotic disease.</p>
<p><em>Image: Head of a “Gray-headed Flying Fox,” Pteropus poliocephalus.The gray-headed flying fox is a member of the order Chiroptera, and the subfamily Megachiroptera, or “megabats," which range from 2.4 to 16 inches in length.</em></p>
<p><em>The natural reservoir for Hendra virus is thought to be flying foxes (bats of the genus Pteropus) found in Australia. The natural reservoir for Nipah virus is still under investigation, but preliminary data suggest that bats of the genus Pteropus are also the reservoirs for Nipah virus in Malaysia.</em></p>
<p>UNC, Vanderbilt discover a new <a target="_blank" href="http://news.vanderbilt.edu/2012/11/unc-vanderbilt-discover-a-new-live-vaccine-approach-for-sars-and-novel-coronaviruses/?utm_source=BNT,+November+15,+2012&utm_campaign=BNT111512&utm_medium=email">live vaccine approach</a> for SARS and novel coronaviruses.</p>
<p>FDA <a target="_blank" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm328982.htm">approves</a> first seasonal influenza vaccine manufactured using cell culture technology. Related: FDA panel endorses <a target="_blank" href="http://www.cidrap.umn.edu/cidrap/content/influenza/avianflu/news/nov1512vrbpac.html">H5N1 vaccine with adjuvant</a>; could become the first licensed adjuvanted flu vaccine.</p>
<p>As a new Ebola <a target="_blank" href="http://www.monitor.co.ug/News/National/Ebola-deaths-at-five-as-40-are-monitored/-/688334/1623488/-/5irw9nz/-/index.html?utm_source=BNT,+November+19,+2012&utm_campaign=BNT111912&utm_medium=email">outbreak</a> in Uganda kills at least five people, Canadian scientists have shown that the deadliest form of the ebola virus could be <a target="_blank" href="http://www.bbc.co.uk/news/science-environment-20341423?utm_source=BNT,+November+16,+2012&utm_campaign=BNT111612&utm_medium=email">transmitted by air</a> between species.  <strong>Journal article</strong>, from <em>Scientific Reports</em>: <a target="_blank" href="http://www.nature.com/srep/2012/121115/srep00811/full/srep00811.html">Transmission of Ebola virus from pigs to nonhuman primates</a></p>
<p>Structural vaccinology <a target="_blank" href="http://www.nature.com/nrmicro/journal/v10/n12/abs/nrmicro2893.html?lang=en?WT.ec_id=NRMICRO-201212&utm_source=BNT,+November+16,+2012&utm_campaign=BNT111612&utm_medium=email">starts to deliver</a> (<em>Nature </em>abstract, subscription required to view full text).</p>
<p>Open access <a target="_blank" href="http://globalbiodefense.com/2012/11/13/open-access-initiative-helps-neglected-tropical-disease-drug-effort/">initiative</a> helps neglected tropical disease drug effort.</p>
<p><strong>Platform technology:</strong> Researchers have <a target="_blank" href="http://globalbiodefense.com/2012/11/07/new-dna-universal-vaccine-platform-technology/">revealed</a> the design of a universal platform for delivering highly potent DNA vaccines.</p>
<p><strong>Workshop: </strong>HHS is sponsoring a <a target="_blank" href="http://oba.od.nih.gov/biosecurity/internationalwebcast.html#Dec2012?utm_source=BNT,+November+26,+2012&utm_campaign=BNT112612&utm_medium=email">workshop</a> on <strong>December 17-18, 2012</strong>: Gain-of-Function Research on Highly Pathogenic Avian Influenza H5N1 Viruses: An International Consultative Workshop</p>
<h3><strong>Government Contracting and Business</strong></h3>
<p><strong>Funding: </strong>The U.S. National Institutes of Health recently issued a funding opportunity <a target="_blank" href="http://vaccinenewsdaily.com/national_institutes_of_health_/320599-nih-seeks-applicants-for-international-research/">announcement</a> to support the formation of international collaborative partnerships in biomedical research and training. Letters of interest due <strong>December 18, 201</strong>2, with completed applications due in January.</p>
<p><a target="_blank" href="http://www.washingtonpost.com/local/virginia-politics/federal-cuts-would-take-heavy-toll-on-small-contractors/2012/11/16/90ddbd3c-2f3e-11e2-9f50-0308e1e75445_story.html?wpisrc=nl_headlines"><img style="float: right; margin: 10px;" alt="Rock climber crawling across the face of a mountain cliff" src="http://assets1.csc.com/dvc/images/rock_climber_on_cliff.gif" height="167" width="250" /></a>Don’t fall off the fiscal cliff. Law firms <a target="_blank" href="http://www.venable.com/sequestration--what-government-contractors-need-to-know-06-20-2012/">Venable LLP</a> and <a target="_blank" href="http://www.wileyrein.com/publications.cfm?sp=articles&newsletter=3&id=7833">Wiley Rein LLP</a> offer tips on how government contractors can prepare for the effects of sequestration (and, if it doesn’t happen, its long-lasting budget impacts).  Federal cuts would take a <a target="_blank" href="http://www.washingtonpost.com/local/virginia-politics/federal-cuts-would-take-heavy-toll-on-small-contractors/2012/11/16/90ddbd3c-2f3e-11e2-9f50-0308e1e75445_story.html?wpisrc=nl_headlines">heavy toll</a> on small contractors.</p>
<p>Bid protests in fiscal 2012 <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2012/11/bid-protests-in-fiscal-2012-up-5.html?ana=e_wash_fedbiz&s=newsletter&ed=2012-11-15">up 5 percent</a> from last year.</p>
<p>NIH Director Dr. Francis Collins has introduced a <a target="_blank" href="http://www.biohealthinnovation.org/index.php/bhi-news-articles/735-nih-director-introduces-new-blog?utm_source=biohealth-innovation-news&utm_medium=gazetty&utm_campaign=11-13-2012">new blog</a>.</p>
<p>House lawmakers <a target="_blank" href="http://thehill.com/blogs/healthwatch/medical-devices-and-prescription-drug-policy-/267977-reps-slam-fda-at-testy-hearing-on-meningitis-outbreak">criticized</a> U.S. drug regulators for failing to prevent an outbreak of fungal meningitis that has killed 32 people; FDA chief urges Congress to “clarify and strengthen the FDA’s oversight of drug compounders.”</p>
<p>Homeland Security tries <a target="_blank" href="http://www.nti.org/gsn/article/dhs-tries-monitoring-social-media-signs-biological-attacks/">monitoring</a> social media for signs of biological attacks.</p>
<p><a target="_blank" href="http://blogs.nature.com/spoonful/2012/11/computer-program-aims-to-rank-vaccine-development-decisions.html">Computer program</a> from the U.S. Institute of Medicine aims to rank vaccine development decisions.</p>
<h3></h3>
<h3><strong>Reports and Resources</strong></h3>
<p>Public Hearing/Request for Comments: <a target="_blank" href="https://www.federalregister.gov/articles/2012/11/16/2012-27931/establishing-a-list-of-qualifying-pathogens-that-have-the-potential-to-pose-a-serious-threat-to">Establishing a list of qualifying pathogens</a> that have the potential to pose a serious threat to public health (<strong>December 18, 2012</strong>).</p>
<p><strong>Workshop: </strong> The U.S. Department of Health and Human Services (HHS) will host a two-day <a target="_blank" href="http://oba.od.nih.gov/biosecurity/internationalwebcast.html#Dec2012">workshop</a> <strong>December 17 and 18, 2012</strong> to discuss issues related to dual-use H5N1 avian influenza research. The event in Bethesda, Md. is open to the public but will not be webcast.</p>
<p><strong>Opinion: </strong><a target="_blank" href="http://www.theatlantic.com/magazine/archive/2012/11/hacking-the-presidents-dna/309147/?single_page=true">Hacking the President’s DNA</a>: are personalized bioweapons a near-term threat?</p>
<p><strong>Opinion: </strong>50 Shades of Grey in Scientific Publication: <a target="_blank" href="http://www.huffingtonpost.com/dr-douglas-fields/50-shades-of-grey-in-scientific-publication-how-digital-publishing-is-harming-science_b_2155760.html">How Digital Publishing Is Harming Science</a></p>
<p><strong>Apps: </strong>HHS offers <a target="_blank" href="http://www.hhs.gov/digitalstrategy/mobile/mobile-apps.html">25 mobile apps</a> for public health</p>
<p><strong>eBook:</strong> <a target="_blank" href="http://www.fiercebiotech.com/offer/movingpreclinical?utm_medium=nl&utm_source=internal&source=library">Moving from Preclinical to Clinical</a>, from FierceBiotech (registration required)</p>
<hr />
<h2></h2>
<h2><strong>Upcoming Events</strong></h2>
<p><strong>December 5-7, 2012, San Diego, CA –</strong> <a target="_blank" href="http://www.bioconferences.com/Conferences/DNA/index.aspx">DNA Vaccines 2012</a>, 20th anniversary meeting</p>
<p><strong>December 6, 2012, virtual –</strong> Webinar: <a target="_blank" href="http://www.sharevault.com/resources/webinars/business-development-and-licensing/#&slider1=1">Building a Successful Business Development and Licensing Strategy</a></p>
<p><strong>December 13, 2012, virtual – </strong>Webinar: Be Where the Biopharma Conversation Is - Get Social with BioWorld <em>(Note: this event has been canceled)</em></p>
<p><strong>January 21-25, 2013, Palm Springs, CA –</strong> <a target="_blank" href="http://www.chi-peptalk.com/">Pep Talk</a>: The Protein Science Week – now accepting <a target="_blank" href="http://www.chi-peptalk.com/peptalk_content.aspx?ekfrm=116231">speaker applications</a></p>
<p><strong>January 24-25, 2013, Arlington, VA – 3rd Annual <a target="_blank" href="http://www.exlpharma.com/clinicalCAPA">Developing CAPAs in the GCP Environment</a></strong></p>
<p></p>
<p><strong><strong>January 28-30, 2013, Washington, DC </strong></strong><strong>– <a href="http://www.vaccine-forum.com/">Phacilitate Vaccine Forum</a> Washington, co-located with the <a target="_blank" href="http://www.proteins-forum.com/">Protein Therapeutics Forum</a> and <a target="_blank" href="http://www.cgt-forum.com/">Cell &amp; Gene Therapy Forum</a></strong></p>
<p></p>
<p><strong><strong><a target="_blank" href="http://www.scopesummit.com/"><img style="float: right; margin: 10px;" alt="Miami Beach view of pastel Art Deco buildings with palm trees and bright blue sky" src="http://assets1.csc.com/dvc/images/miami_beach_art_deco.gif" height="166" width="250" /></a>February 4-8, 2013, Boston, MA </strong>– <a target="_blank" href="http://csdd.tufts.edu/courses/postgraduate_course">Postgraduate Course</a> in Clinical Pharmacology, Drug Development and Regulation</strong></p>
<p><strong><strong>February 5-7, 2013, Miami, FL – </strong></strong>4th Annual Summit for Clinical Ops Executives (<a target="_blank" href="http://www.scopesummit.com/">SCOPE</a>)</p>
<p><strong>February 11-12, 2013, San Francisco, CA – </strong>Genomics in Medicine (part of <a target="_blank" href="http://www.triconference.com/mmtc_content.aspx?id=107638">Molecular Med Tri-Con</a>) - <a target="_blank" href="http://www.triconference.com/mmtc_content.aspx?ekfrm=116905">speaker proposals</a> now being accepted</p>
<p><strong>March 5-7, 2012, Pune, India –</strong> <a target="_blank" href="http://www.imapac.com/index.php?page=VaccineWorldSummitIndia2013">Vaccine World Summit India 2013</a> – <a target="_blank" href="http://www.imapac.com/index.php?page=VaccineWorldSummitIndia2013Enquiry">speaker abstracts</a> now being accepted</p>
<p><strong>March 11-13, 2012, Rosslyn, VA – </strong>International Society for BioProcess Technology ISBioTech 3rd Annual Meeting, including Baculovirus Expression Technology and Viral Vectors &amp; Vaccines tracks - call for papers and posters now open</p>
<p><strong>April 22-24, 2013, Baltimore, MD – </strong>NFID 16th Annual <a target="_blank" href="http://www.cvent.com/events/16th-annual-conference-on-vaccine-research/event-summary-db97bedd5ee041eeb09d971650f76be0.aspx">Conference on Vaccine Research</a> - <a target="_blank" href="http://www.cvent.com/events/16th-annual-conference-on-vaccine-research/custom-19-db97bedd5ee041eeb09d971650f76be0.aspx">speaker abstracts</a> are due <strong>December 21, 2012</strong></p>
<p><strong>April 22-25, 2013, Chicago, IL –</strong> <a target="_blank" href="http://convention.bio.org/">BIO International Convention</a></p>
<p><strong>April 29-May 3, 2013, Boston, MA – </strong><a target="_blank" href="http://www.pegsummit.com/">9th Annual PEGS</a>, the Essential Protein Engineering Summit</p>
<p><strong>May 9-10, 2013, San Diego, CA – </strong>7th Annual <a target="_blank" href="http://knowledgefoundation.com/viewevents.php?event_id=291&act=evt&utm_source=Campaigner&utm_campaign=Sample_Prep_Call_for_Speakers&campaigner=1&utm_medium=HTMLEmail">Sample Prep 2013</a> - <a target="_blank" href="http://knowledgefoundation.com/become_speaker.php">speaker abstracts</a> accepted until <strong>January 4, 2013</strong></p>
<p><strong>June 18-19, 2013, Washington, DC area –</strong> 21st <a target="_blank" href="http://www.knowledgefoundation.com/viewevents.php?event_id=290&act=evt&utm_source=Campaigner&utm_campaign=Biodetection_2013_Call_for_Speakers&campaigner=1&utm_medium=HTMLEmail">Biodetection Technologies</a> - <a target="_blank" href="http://knowledgefoundation.com/become_speaker.php">speaker abstracts</a> accepted until <strong>January 14, 2013</strong></p>
<p><strong>June 23-27, 2013, Boston, MA –</strong> <a target="_blank" href="http://www.diahome.org/en/Meetings-and-Training/Find-Meetings-and-Training/Meeting-Details.aspx?ProductID=30075&EventType=Annual%20Meeting">DIA 49th Annual Meeting</a> - Advancing Therapeutic Innovation and Regulatory Science - <a target="_blank" href="http://www.diahome.org/Get-Involved/Submit-Abstracts/Submit-a-New-Abstract/Select-Meeting.aspx">call for posters</a>, due <strong>February 28, 2013</strong></p>
<hr />
<h2><strong>Work With Us</strong></h2>
<p><strong>Sources Sought notice:</strong> Still time to respond! We're looking for contract manufacturing organizations (CMOs) capable of performing routine commercial-scale manufacturing of a recombinant protein from a <em>Pichia pastoris</em> expression system. Responses due <strong>December 3, 2012</strong>.</p>
<p><strong>Team with us: </strong>DynPort can help you apply your technology to new programs, or advance your product from proof-of-concept into clinical trials. <a target="_blank" href="../../ds/16190/16326-team_with_dvc.html">Learn more</a></p>
<hr />
<p><a target="_blank" href="http://twitter.com/dynport"><img src="http://assets1.csc.com/dvc/images/twitter2.png" alt="Follow us on Twitter" height="27" width="160" /></a> <a target="_blank" href="http://www.linkedin.com/company/dynport-vaccine-company-llc-a-csc-company"><img src="http://assets1.csc.com/dvc/images/linkedin.png" alt="Follow us on LinkedIn" height="27" width="158" /></a> <a target="_blank" href="../28826-bugs_and_drugs.html"><img src="http://assets1.csc.com/dvc/images/Blog_Button_small.jpg" alt="DVC Bugs and Drugs Blog" height="27" width="160" /></a></p>
<p> </p>
<p>View previous editions of this newsletter in our <a target="_blank" href="../41185-dvc_news_updates_for_partners.html">archive</a> or learn more about DVC on our <a target="_blank" href="../../../dvc.html">website</a>.</p>
<p>Like this newsletter? Plan to attend one of the events above? Have an idea for a topic we should cover? Let us know in the comments below!</p>
<p><em>DVC is not necessarily affiliated with third parties listed in this newsletter, nor does linking imply endorsement. The information herein is provided as a service for informational purposes only.</em></p>
<p>We'd love to hear from you! Feel free to comment below. Due to corporate policy, comments are moderated--we approve them during business hours Monday through Friday.</p>
<div id="_mcePaste" style="position: absolute; width: 1px; height: 1px; overflow: hidden; top: 0px; left: -10000px;">How to get more from your trade show investment</div></p>
    </section>
    </article>
		<div id="gigyaReactionsHolder"></div>


<div id="commentsPrefix"><div>COMMENTS</div></div>
<div id="gigyaSpecificityOverloader" class="gso"><div id="gigyaCommentsHolder"></div></div>


<script>
var delayedLoadComments = function () {
  //Setting up some vars used by all of the following Gigya plugins
  var defaultUserAction = new gigya.socialize.UserAction();
  defaultUserAction.setTitle(document.title);
  defaultUserAction.setLinkBack(window.location);

  var urlParts = window.location.pathname.split('/');
  var urlSlug = urlParts[urlParts.length -1].split('#')[0].split('?')[0];


  //########START REACTIONS########
  var textReactions=[
    {
      text: '',
      ID: 'thumbs_up',
      iconImgUp:'/images/new/icons/reaction_icons-thumbs_up.png',
      iconImgOver:'/images/new/icons/reaction_icons-thumbs_up.png',
      tooltip:'I give this article my thumbs up!',
      feedMessage: 'Thumbs Up!',
      headerText:'You give this article a thumbs up'
    }
    ,{
      text: '',
      ID: 'thumbs_down',
      iconImgUp:'/images/new/icons/reaction_icons-thumbs_down.png',
      iconImgOver:'/images/new/icons/reaction_icons-thumbs_down.png',
      tooltip:'I give this article my thumbs down.',
      feedMessage: 'Thumbs Down',
      headerText:'You give this article a thumbs down'
    }
  ];
  // Step 3: Define the Reactions Plugin's params object
  var reactionParams ={
    disabledProviders: 'twitter',
    barID: urlSlug, //  Identifier of the content to which this reaction refers
    containerID: 'gigyaReactionsHolder',  // Reactions Plugin DIV Container
    reactions: textReactions,  // The reaction array from Step 1
    userAction: defaultUserAction,  // The UserAction object from Step 2
    bodyText: 'Share it with your friends:', // optional - text that appears in the Share popup
    showCounts: 'top', // optional - displays the counters on top of the buttons
    cid:'',
    onReactionClicked:gigyaEventHandlers.onReactionClicked,
    onSendDone:gigyaEventHandlers.onSendDone
  };
  // Step 4: Load the Reactions Plugin:
  gigya.socialize.showReactionsBarUI(reactionParams);
  //########END REACTIONS########

  
  //########START COMMENTS########
  var commentsTemplates = {
    loginCanvas_loggedIn: '<div class="gig_photoHolder">$photoDiv</div><div class="gig_username">$username</div><div class="gig_logout"><a href="/utils/logout_visitor">Log&nbsp;Out</a></div>',
    loginCanvas_loggedOut:'<div class="gig_photoHolder"><img src="/images/new/icons/comment_default_user_icon.png" width="48" height="48" alt=""></div><div class="gig_loginmessage"><h3>Post a new comment</h3><p>You must be logged in to post comments.</p></div><div class="gig_login"><a href="javascript:void(0);" onclick="accountPopupWindow(\'account_login\');"><img src="/images/new/icons/comment_login_button.png" width="144" height="24" alt="Login"></a></div>'
  };
  //Good browsers get '100%', and Gigya's internals turn this number plus some math into 'NaNpx',
  //which is applied to the `width` value of the style attribute on EVERY ELEMENT GIGYA TOUCHES.
  //As 'NaNpx' is an invalid CSS width value, all of Gigya's width values fail, and mine take precedence.
  //IE7 & 8 try someElement.style.width = (NaN) + 'px' and error out, breaking the whole showCommentsUI invocation.
  //No responsive comments for IE7 or 8!
  var gigyaCommentsWidth = '100%';
  if($.browser.msie === true && ($.browser.version === '8.0' || $.browser.version === '7.0')){
    gigyaCommentsWidth = 640;
  }
  var showCommentsParams ={
    categoryID: "Unmoderated",
    streamID: "92214",
    useSiteLogin: true,
    onSiteLoginClicked: gigyaEventHandlers.onSiteLoginClicked,
    containerID: 'gigyaCommentsHolder',
    cid:'',
    templates: commentsTemplates,
    width:gigyaCommentsWidth,
    enabledShareProviders: 'facebook,yahoo,linkedin,pinterest',
    onSendDone: gigyaEventHandlers.onSendDone,
    onCommentSubmitted: gigyaEventHandlers.onCommentSubmitted,
    onLoad:function(){
      if(mobileDevice){
        myScroll.refresh();
      }
    }
  }
  gigya.socialize.showCommentsUI(showCommentsParams);
  //########END COMMENTS########
  
}
$csc().gigya.register(delayedLoadComments);
</script>
    </article>

  <aside class="sideBar">        
      <div>
        Welcome! Thanks for checking out news for our partners from
DynPort Vaccine Company LLC, a CSC company.<br><br>

We’ve been working in biopharmaceutical product development as a
government contractor since 1997, and have learned a few things along
the way. <strong>But... this newsletter isn't about us. </strong> <br><br>

Our goal is to share information with our partners and
potential partners, who may be interested in developments related to
government contracting and biopharmaceuticals.  (We send updates no more than once a month, so no need to worry about us overwhelming your inbox!)<br><br>

<strong>To receive these updates via email, <a href="../../ds/16190/41114-join_our_partners_e_mail_list.html"><strong>sign up here</strong></a>.</strong>  
      </div>
    </aside>
     </div>
</section>
      
<aside id="myRcmds">
  <header id="myRcmdsHeader">
    <div id="myRcmdsPersHeader"><strong>CSC Recommendations</strong></div>
    <div id="myRcmdsPersonalization">
      <div id="persIcon"><img src="../../../images/new/icons/comment_default_user_icon.png" alt=""></div>
      <div id="persButtons">
        <ul>
          <li id="myrecs_logout"><a href="../../../utils/logout_visitor.html">LOG OUT</a></li>
          <li id="myrecs_edit"><a onclick="accountPopupWindow('editprofile');" href="javascript:void(0);">EDIT PROFILE</a></li>
        </ul>
      </div>
      <div id="persProfile"><span id="myrecs_visitor_name"></span><span id="myrecs_job_title"></span></div>
    </div>
  </header>
  <div id="myRcmdsTrigger"><a id="myRcmdsChevronHolder"><span id="myRcmdsChevron">&laquo;</span></a></div>
  <section id="recs_content">
    <label>Recommended Reading</label>
    <div id="recs_div">

      <article class="contentNode">
        <a class="imgAnchor" href="../../../banking/insights/98313-changing_the_way_banks_do_business-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_insight' height="50" width="50" alt="Changing the Way Banks Do Business" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../banking/insights/98313-changing_the_way_banks_do_business-ref=rec&dyn=0.html">Changing the Way Banks Do Business</a></strong><p>CSC and SAP together deliver end-to-end banking transformation with a portfolio of...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../application_services/success_stories/78846-coca_cola_supply_chain_management_success_story-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_success' height="50" width="50" alt="Coca-Cola Supply Chain Management Success Story" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../application_services/success_stories/78846-coca_cola_supply_chain_management_success_story-ref=rec&dyn=0.html">Coca-Cola Supply Chain Management Success Story</a></strong><p>Coca-Cola has dominated the beverage market for over a century, yet still values...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../innovation/insights/92142-the_future_of_3d_printing_services_and_manufacturing-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_insight' height="50" width="50" alt="The Future of 3D Printing Services and Manufacturing" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../innovation/insights/92142-the_future_of_3d_printing_services_and_manufacturing-ref=rec&dyn=0.html">The Future of 3D Printing Services and Manufacturing</a></strong><p>CSC explores the future of 3D printing and manufacturing, as 3D printing manufacturing...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../communications_media_and_entertainment/offerings/16514/69782-csc_cloudbill-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_offer' height="50" width="50" alt="CSC CloudBill" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../communications_media_and_entertainment/offerings/16514/69782-csc_cloudbill-ref=rec&dyn=0.html">CSC CloudBill</a></strong><p>An on-demand billing and subscription management Software as a Service for digital...</p></section>
      </article>

    </div>
  </section>
</aside>
<script type="text/javascript">
  var f = true;
  var myrecs_rec = 'recs_item_va';
  var myrecs_param = 'entity.id=92214';
</script>

      <!-- Content End -->
      <footer>
        <div class="wrapper">

          <section id="relationsBucket">
            <nav>
              <ul>
                <li><a class="redTri" href="../../../about_us.html"><strong>ABOUT CSC</strong></a>
                </li>
                <li><a class="blueTri" href="../../../success_stories.html"><strong>SUCCESS STORIES</strong></a>
                </li>
                <li><a class="lightBlueTri" href="../../../careersus/flxwd/16005-careers.html"><strong>CAREERS</strong></a>
                </li>
                <li><a class="purpleTri" href="../../../global_alliances.html"><strong>GLOBAL ALLIANCES</strong></a>
                </li>
                <li><a class="yellowTri" href="../../../newsroom.html"><strong>NEWSROOM</strong></a>
                </li>
                <li><a class="greenTri" href="../../../investor_relations.html"><strong>INVESTOR RELATIONS</strong></a>
                </li>
              </ul>
            </nav>
          </section>

          <section id="newsEventsBucket">
                        <strong class="headline">
              CSC WIRE</strong>
            <nav>
              <ul>
<li><a href='../../../investor_relations/press_releases/106413.html'>CSC Delivers Continued Earnings, Margin and Cash Flow Growth</a></li>
<li><a href='../../../newsroom/press_releases/105673-hcl_technologies_and_csc_announce_strategic_partnership_to_address_the_application_modernization_market.html'>HCL Technologies and CSC Announce Strategic Partnership to Address the Application Modernization Market</a></li>
<li><a href='../../../newsroom/press_releases/105677-csc_to_host_investor_call_to_discuss_strategic_partnership_with_hcl_technologies_on_wednesday_january_15_2014.html'>CSC Hosts Investor Call to Discuss Strategic Partnership with HCL Technologies</a></li>

              </ul>
            </nav>
          </section>

          <section id="contactBucket">
            <div class="thumbBucket">
  <strong class="headline">
    Engage With Us</strong>
  <!-- comment to hide this section and reveal the following section -->

 <section>
    <aside>
      <a href="../../../townhall.html" class="townHall">
	  </a>
    </aside>
    <article class="doubleLine">
      <a href="../../../townhall.html">View On-Demand <br>Town Hall Events</a>
    </article>
  </section> 

  <!-- end townhall section -->
  <!-- uncomment following content for where there is a town hall.  Be sure to specify event title and include ref=blinkgif. -->
<!-- 
    <section>
    <aside>
      <a href="/townhall/events/105269-how_will_regulatory_changes_impact_disaster_recovery?ref=blinkgif" class="townHallLive">
	  </a>
    </aside>
    <article class="doubleLine">
      <a href="/townhall/events/105269-how_will_regulatory_changes_impact_disaster_recovery?ref=blinkgif"><span class='alert'>Live Now in the Town Hall</span><br />How Will Regulatory Changes Impact Disaster Recovery?</a>
    </article>
  </section>
-->
  <!-- end live townhall section -->
  <section class="lef">
    <aside>
      <a href="../../../innovation.html" class="feedback">
        <!--img src="/images/new/icons/feedback.png" alt="Subscribe to our Newsletters" /--></a>
    </aside>
    <article>
      <a href="javascript:void(0);" onclick="premiumContentPopupWindow({id: '7829', mediaType: 'newsletter', type: ''}); ">Get our Newsletters</a><br />
     </article>
  </section>

  <section>
    <aside>
      <a href="../../../engage_communities.html" class="community">
        <!--img src="/images/new/icons/communities.png" alt="CSC Communities" /--></a>
    </aside>
    <article>
      <a href="../../../engage_communities.html"> Join our Communities</a>
    </article>
  </section>

  <section class="feedbackSection">
    <aside>
      <a href="javascript:void(0);" onclick="surveyPopupWindow('http://survey.omniture.com/d1/hosted/b22135be47','',1000,600);" id="engageWithUs" class="lef">
        <!--img src="/images/new/icons/forums.png" alt="Feedback" /--></a>
    </aside>
    <article>
      <a href="javascript:void(0);" onclick="surveyPopupWindow('http://survey.omniture.com/d1/hosted/b22135be47','',1000,600);">Give Your Feedback</a>
    </article>
  </section>
</div>
          </section>

          <section id="socialBucket">
            <strong class="headline">
              Follow Us</strong>
            <nav class="social footer">
              <!-- Follow Bar plugin DIV container -->
              <div id="gigyaFollowFooter"></div>
              <div id="gigyaFollowFooterMobile">
                <ul>
                  <li><a href="http://www.facebook.com/pages/CSC/51414306171?v=app_101332539959471" class="facebook" target="_blank">&nbsp;</a></li>
                  <li><a href="http://twitter.com/#!/CSCNews" class="twitter" target="_blank">&nbsp;</a></li>
                  <li><a href="http://www.linkedin.com/company/csc" class="linkedin" target="_blank">&nbsp;</a></li>
                  <li><a href="../../../feeds.html" class="rss" target="_blank">&nbsp;</a></li>
                  <li><a itemprop="publisher" href="https://plus.google.com/118416213869891352236" class="googleplus clearText" target="_blank">CSC</a></li>
                </ul>
              </div>
              <ul>
                <li>
                  <a href="http://www.youtube.com/user/csc" target="_blank" class="youtube clearText">&nbsp;</a>
                </li>
              </ul>
            </nav>
          </section>
          <section id="corpBucket">
            <nav class="corpInfo">
              <ul>
  <li><a href="../../../legal.html">Legal</a>&nbsp;|&nbsp; </li>
  <li><a href="../../../privacy.html">Privacy</a>&nbsp;|&nbsp; </li>
  <li><a href="../../../site_map.html">Site Map</a>&nbsp; </li>
  <li>&copy; Computer Sciences Corp </li>
</ul>

            </nav>
          </section>
        </div>
      </footer>
    </div>
  </div>
  <!-- scripts -->
  <script type="text/javascript" src="http://www.google.com/jsapi?key=ABQIAAAAmQdrOgG-5AIXvyPvLF37UxSkoY0ZZixtVMJANGkGJlQelbG63hREfyZFOAPj93RuUqgytyCufo6x5Q">
</script>

<script type="text/javascript" src="http://assets2.csc.com/javascripts/googlefeedfetcher.js">

/***********************************************
* gAjax RSS Feeds Displayer- (c) Dynamic Drive (www.dynamicdrive.com)
* This notice MUST stay intact for legal use
* Visit http://www.dynamicdrive.com/ for full source code
***********************************************/

</script>

<style type="text/css">

.labelfield{ /*CSS for label field in general*/
color:brown;
font-size: 90%;
}

.datefield{ /*CSS for date field in general*/
color:gray;
font-size: 90%;
}

#example1 li{ 
margin-bottom: 8px;
padding-bottom: 8px;
margin-left:-28px;
text-indent:0px;
}
</style>
  <!-- end of scripts -->
  
</div>
 <script src="../../../javascripts/user/twistage_omniture-min-19b876fa394902ce781dfc20f23ba899.js" type="text/javascript"></script>
 <img src="http://a.company-target.com/pixel?id=1372868710&type=js" alt="pixel" style="display:none"/>
<img src="http://a.company-target.com/pixel?id=1372868656&type=js" alt="pixel" style="display:none"/>
 <script type="text/javascript">
    var _elqQ = _elqQ || [];
    _elqQ.push(['elqSetSiteId', '3015']);
    _elqQ.push(['elqTrackPageView']);
    
    (function () {
        function async_load() {
            var s = document.createElement('script'); s.type = 'text/javascript'; s.async = true;
            s.src = '//img.en25.com/i/elqCfg.min.js';
            var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore(s, x);
        }
        if (window.addEventListener) window.addEventListener('DOMContentLoaded', async_load, false);
        else if (window.attachEvent) window.attachEvent('onload', async_load); 
    })();
</script>
</body>
</html>
